Real world population-based outcome analysis of small lymphocytic lymphoma (SLL) in British Columbia (BC)

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Social determinants of health and long-term survival in chronic lymphocytic leukemia/small lymphocytic lymphoma: A population-based analysis of 118,667 patients2025
2. 2Real-world chronic lymphocytic leukemia (CLL)–specific biomarker testing patterns and frontline treatment patterns in patients with CLL/small lymphocytic lymphoma (SLL)2025
3. 3Interim results of an multicenter observational clinical study on treatment strategies for chronic lymphocytic leukemia/small lymphocytic lymphoma in Russia2025
4. 4Real-world outcomes in T-cell/histiocyte-rich large B-cell lymphoma: Insights from the largest u.S. cohort to date2025
5. 5Other cancers in patients with chronic lymphocytic leukemia/SMALL lymphocytic lymphoma2025